# Hypertensive Emergency Targets

Manage hypertensive emergency by identifying the injured organ before selecting a blood pressure target. Most patients require controlled intravenous reduction of mean arterial pressure, while aortic dissection, stroke, pulmonary edema, acute coronary syndromes, and pregnancy require syndrome-specific targets and agents.

**Clinical question:** What blood pressure reduction target and timing should be used for each hypertensive emergency syndrome?

Updated: 2026-09-15T17:44:21.964646+00:00

## What matters in practice
- Severe blood pressure elevation becomes a hypertensive emergency only when acute hypertension-mediated organ injury is present; the treatment target is determined by the organ-injury syndrome, not the presenting blood pressure alone. [6][13][17]
- For most hypertensive emergencies, reduce mean arterial pressure by no more than 20% to 25% in the first hour, then toward 160/100 to 110 mm Hg over 2 to 6 hours, with further cautious reduction during the next 24 to 48 hours. [2][12][13][16][20]
- Acute aortic dissection requires immediate anti-impulse therapy, generally intravenous esmolol within 5 to 10 minutes and systolic blood pressure below 120 mm Hg; add a vasodilator only after beta-blockade if pressure remains elevated. [13][15]
- Do not use intravenous drugs or rapid blood pressure reduction for severe asymptomatic hypertension without acute organ injury; initiate or intensify chronic oral therapy and reduce blood pressure over days to weeks. [2][18][19]
- In hypertensive acute pulmonary edema, use intravenous nitroglycerin, clevidipine, or nitroprusside; avoid beta-blockers in acute pulmonary edema. [11][20]

## Confirm acute organ injury before applying emergency targets

A number alone does not establish an indication for rapid intravenous blood pressure reduction.

Classify the presentation as hypertensive emergency when severe blood pressure elevation is accompanied by acute hypertension-mediated organ injury, including encephalopathy, intracerebral hemorrhage, acute ischemic stroke, acute myocardial infarction or unstable angina, acute left ventricular failure with pulmonary edema, acute kidney injury, aortic dissection, or eclampsia. A systolic blood pressure of 180 mm Hg or greater and/or diastolic blood pressure of 120 mm Hg or greater is a common threshold for severe elevation, but organ injury—not a fixed pressure threshold—drives emergency treatment. [6][13][16][17][20]

Use a targeted evaluation to identify the branch that changes the pressure goal: neurologic deficit or altered mentation prompts stroke or encephalopathy assessment; chest or back pain raises concern for acute coronary syndrome or aortic dissection; hypoxemia with pulmonary edema identifies acute heart failure; and worsening creatinine or oliguria supports acute renal involvement. Obtain electrocardiography and laboratory testing when clinical findings suggest organ injury, and use directed imaging for suspected neurologic or aortic disease. [17][19]

Admit patients with hypertensive emergency for titratable intravenous therapy and continuous hemodynamic monitoring, generally in an intensive care setting. Avoid precipitous reduction because chronic hypertension shifts autoregulation and excessive early lowering can cause cerebral, coronary, or renal hypoperfusion. [2][13][17]
- Treat immediately as an emergency when severe blood pressure elevation accompanies aortic dissection, pulmonary edema, acute coronary ischemia, acute renal failure, stroke or intracranial hemorrhage, encephalopathy, or eclampsia. [13][20]
- Do not equate headache alone, anxiety, medication nonadherence, or a single markedly elevated reading with acute organ injury; assess for the specific injury syndrome before choosing intravenous therapy. [2][17][19]
- Use frequent reassessment of blood pressure and the affected organ system while titrating treatment; the intended target may change as neurologic, respiratory, ischemic, or perfusion findings evolve. [2][13]

*Initial distinction between hypertensive emergency and severe asymptomatic hypertension. [2][13][18][19]*

| Clinical state | Defining finding | Immediate blood pressure strategy | Disposition |
| --- | --- | --- | --- |
| Hypertensive emergency | Severe elevation with acute hypertension-mediated organ injury. [13][17] | Use titratable intravenous therapy with syndrome-specific targets. [2][13] | Hospitalize with continuous monitoring, commonly intensive care. [9][13] |
| Severe asymptomatic hypertension | Typically systolic blood pressure at least 180 mm Hg or diastolic blood pressure at least 110 mm Hg without acute target-organ injury. [18][19] | Do not rapidly lower blood pressure or use parenteral agents; initiate or adjust oral chronic therapy and reduce over days to weeks. [18] | Usually outpatient management; consider admission for escalating pressure, acute organ injury, or inability to adhere to treatment. [18] |

## Use staged reduction for most hypertensive emergencies

Apply this sequence unless the clinical syndrome has a more urgent or different target.

For most hypertensive emergencies, lower mean arterial pressure by no more than 20% to 25% during the first hour. If the patient is clinically stable, continue gradual reduction toward approximately 160/100 to 110 mm Hg during the next 2 to 6 hours, then cautiously toward 130 to 140 mm Hg over the subsequent 24 to 48 hours. [12][13][16][20]

This staged approach applies to many nonstroke emergencies, including hypertensive encephalopathy and acute renal injury, but should not be used as a substitute for the syndrome-specific targets required in aortic dissection, acute ischemic stroke undergoing reperfusion treatment, intracerebral hemorrhage, acute coronary syndrome, pulmonary edema, or pregnancy-related severe hypertension. [2][11][13][20][22]

Choose a short-acting titratable intravenous agent that fits the injury pattern. Commonly recommended options across emergency syndromes include nicardipine, clevidipine, labetalol, esmolol, sodium nitroprusside, nitroglycerin, hydralazine, and phentolamine; selection should prioritize the clinical syndrome and contraindications rather than a universal first-line drug. [12][22]
- Avoid a greater-than-25% first-hour mean arterial pressure reduction in the usual emergency pathway. [13][16]
- Reassess for hypotension, new neurologic deficits, worsening ischemia, declining urine output, or altered mental status during titration; these findings require reassessment of the target and infusion rate. [2][13]
- Use syndrome-specific targets rather than the default pathway when dissection, stroke, intracranial hemorrhage, acute pulmonary edema, acute coronary syndrome, or eclampsia is present. [11][13][20][22]

*Default staged blood pressure reduction for hypertensive emergency when no syndrome-specific exception applies. [12][13][16][20]*

| Time from treatment | Blood pressure objective | Operational implication |
| --- | --- | --- |
| First hour | Lower mean arterial pressure by no more than 20% to 25%. [12][13][16][20] | Use a titratable intravenous agent and continuous monitoring. [2][13] |
| 2 to 6 hours | Reduce toward 160/100 to 110 mm Hg in clinically stable patients. [12][13][16][20] | Continue gradual titration rather than pursuing immediate normotension. [13][16] |
| 24 to 48 hours | Cautiously reduce toward 130 to 140 mm Hg. [12][13] | Transition planning depends on the precipitating syndrome and long-term antihypertensive regimen. [17][22] |

## Use rapid anti-impulse control for dissection and syndrome-directed targets for pulmonary edema or ACS

Aortic dissection is the principal exception to gradual first-hour reduction.

For acute aortic dissection, initiate intravenous esmolol within 5 to 10 minutes to reduce impulse stress and target systolic blood pressure below 120 mm Hg. If systolic pressure remains elevated after beta-blockade, add a vasodilator such as nitroglycerin or nitroprusside; beta-blockade first avoids reflex tachycardia from vasodilator monotherapy. [15]

For hypertensive acute pulmonary edema, select intravenous nitroglycerin, clevidipine, or sodium nitroprusside. Beta-blockers are contraindicated in acute pulmonary edema. Nitroglycerin may be started at 5 mcg/min, with a reported maximum infusion rate of 20 mcg/min; sodium nitroprusside may be started at 0.3 to 0.5 mcg/kg/min, with a reported maximum of 10 mcg/kg/min. [20]

In acute coronary syndrome with hypertension, decrease mean arterial pressure by approximately 20% to 25% over 1 to 2 hours and then more gradually while preparing for emergency intervention. A target systolic pressure below 140 mm Hg is recommended in cited guidance; avoid lowering diastolic pressure below 70 mm Hg because coronary perfusion may be compromised. AHA/ACC guidance cited in the review includes esmolol or labetalol, an ACE inhibitor, and/or nitroglycerin; do not use beta-blockers when moderate to severe pulmonary edema coexists. [11]
- Acute dissection: beta-block first, then add a vasodilator only if further pressure reduction is required; pursue systolic blood pressure below 120 mm Hg. [15]
- Acute pulmonary edema: use nitroglycerin, clevidipine, or nitroprusside; avoid beta-blockade. [20]
- Acute coronary syndrome: avoid excessive diastolic reduction, particularly below 70 mm Hg in cited guidance. [11]

*Blood pressure targets and intravenous agent selection in cardiovascular hypertensive emergencies. [11][15][20]*

| Syndrome | Target and timing | Preferred strategy | Critical exception |
| --- | --- | --- | --- |
| Acute aortic dissection | Initiate immediate control; maintain systolic blood pressure below 120 mm Hg. [15] | Intravenous esmolol within 5 to 10 minutes; add nitroglycerin or nitroprusside after beta-blockade if needed. [15] | Do not begin vasodilator therapy before controlling heart rate and impulse with beta-blockade. [15] |
| Acute pulmonary edema | Use emergency titration; no separate numerical target is specified in the cited source. [20] | Intravenous nitroglycerin, clevidipine, or nitroprusside. [20] | Beta-blockers are contraindicated. [20] |
| Acute coronary syndrome | Reduce mean arterial pressure by 20% to 25% over 1 to 2 hours; target systolic pressure below 140 mm Hg. [11] | Esmolol or labetalol, ACE inhibitor, and/or nitroglycerin. [11] | Avoid diastolic pressure below 70 mm Hg; avoid beta-blockers with moderate to severe pulmonary edema. [11] |

## Match targets to hemorrhage, ischemic stroke reperfusion eligibility, or pregnancy

Neurologic emergencies require different targets because overly rapid reduction can worsen cerebral perfusion.

For intracerebral hemorrhage, AHA/ASA guidance cited in the literature targets systolic blood pressure of 140 mm Hg. In patients presenting with systolic pressure above 220 mm Hg, use greater caution because intensive reduction may cause hypoperfusion in the setting of right-shifted cerebral autoregulation. [2] Other cited guidance recommends reducing systolic pressure to not less than 140 mm Hg within 6 hours when presenting pressure is 150 to 220 mm Hg. [11]

For acute ischemic stroke, do not automatically apply the general hypertensive-emergency target. When thrombolytic therapy is planned, lower blood pressure to below 185/110 mm Hg before treatment; the cited source recommends a goal of approximately 15% reduction during the first 24 hours when blood pressure control is required. [22] Patients undergoing reperfusion therapy may have adverse outcomes when blood pressure is lowered below 140 mm Hg. [12]

Treat acute-onset severe hypertension in pregnancy at systolic blood pressure of at least 160 mm Hg and/or diastolic blood pressure of at least 110 mm Hg as an obstetric emergency. Cited treatment options include labetalol, nicardipine, or hydralazine; eclampsia is an exception to the usual staged reduction approach and requires more immediate control in an intensive care setting. [11][13][22]

For hypertensive encephalopathy without hemorrhage or ischemic stroke-specific considerations, use the default staged reduction pathway with a titratable intravenous agent, rather than immediate normalization. Clevidipine, labetalol, esmolol, nicardipine, fenoldopam, and nitroprusside are listed options. [13][22]
- Intracerebral hemorrhage: target systolic blood pressure about 140 mm Hg; avoid excessive lowering below this threshold in cited recommendations. [2][11]
- Ischemic stroke considered for thrombolysis: achieve blood pressure below 185/110 mm Hg before treatment. [22]
- Pregnancy: systolic blood pressure at least 160 mm Hg or diastolic blood pressure at least 110 mm Hg is acute severe hypertension requiring urgent therapy. [11]

*Blood pressure targets in neurologic and pregnancy-related hypertensive emergencies. [2][11][12][22]*

| Syndrome | Actionable pressure target | Timing or treatment implication | Important limitation |
| --- | --- | --- | --- |
| Intracerebral hemorrhage | Target systolic blood pressure 140 mm Hg. [2] | For systolic pressure 150 to 220 mm Hg, cited AHA/ACC guidance recommends reduction to not less than 140 mm Hg within 6 hours. [11] | Use caution when presenting systolic pressure exceeds 220 mm Hg because intensive lowering may cause hypoperfusion. [2] |
| Ischemic stroke undergoing thrombolysis | Blood pressure below 185/110 mm Hg before thrombolytic therapy. [22] | When control is required, cited guidance uses approximately 15% reduction in the first 24 hours. [22] | Avoid extrapolating hemorrhage targets; lowering below 140 mm Hg during reperfusion therapy is associated with adverse outcomes. [12] |
| Acute severe hypertension in pregnancy or eclampsia | Treat at systolic blood pressure at least 160 mm Hg and/or diastolic blood pressure at least 110 mm Hg. [11] | Use urgent intravenous treatment; labetalol, nicardipine, and hydralazine are listed options. [22] | Eclampsia requires more immediate and aggressive control than the standard staged pathway. [13] |

## Treat acute renal involvement with controlled intravenous reduction and avoid emergency treatment when injury is absent

Renal dysfunction changes agent selection and lowers the threshold for targeted evaluation.

When severe hypertension is accompanied by acute renal failure, cited preferred intravenous options include clevidipine, fenoldopam, and nicardipine. Fenoldopam may be initiated at 0.1 to 0.3 mcg/kg/min and titrated up to 1.6 mcg/kg/min; nicardipine may be initiated at 5 mg/h and titrated up to 30 mg/h. [20] In an emergency-department cohort with renal dysfunction, 92% of patients receiving intravenous nicardipine reached target systolic pressure within 30 minutes versus 78% receiving labetalol. [20]

In patients with chronic kidney disease, heart failure, coronary artery disease, or previous stroke who have severe pressure elevation without clear acute injury, use a lower threshold for creatinine testing, electrocardiography, or imaging when symptoms or examination findings raise concern for evolving organ injury. [19] Do not infer acute kidney injury from chronic creatinine elevation without evidence of an acute change or compatible clinical syndrome.

After stabilization, identify and address the precipitant, including medication nonadherence, renal or endocrine disorders, and sympathomimetic drug exposure when relevant. Patients without acute organ injury should receive initiation or adjustment of oral antihypertensive therapy rather than intravenous treatment; gradual pressure reduction over several days to weeks is recommended. [15][17][18]
- Acute renal failure with hypertensive emergency: consider nicardipine, clevidipine, or fenoldopam and use the default staged reduction target unless another syndrome supersedes it. [20]
- Severe asymptomatic hypertension: immediate diagnostic testing rarely changes short-term management, and parenteral therapy is not indicated. [18]
- Consider hospital admission without documented acute injury when blood pressure is escalating, acute injury emerges, or treatment adherence cannot be assured. [18]

*Renal and post-stabilization decisions in severe hypertension. [18][19][20]*

| Finding | Next action | Blood pressure approach |
| --- | --- | --- |
| Acute renal failure with hypertensive emergency | Use titratable intravenous clevidipine, fenoldopam, or nicardipine; monitor response and renal trajectory. [20] | Use staged reduction: no more than 20% to 25% in the first hour, then toward 160/100 to 110 mm Hg over 2 to 6 hours unless another emergency syndrome dictates otherwise. [13][20] |
| Chronic kidney disease without definite acute injury | Use a lower threshold for targeted laboratory testing, electrocardiography, or imaging if symptoms suggest evolving injury. [19] | Do not use emergency intravenous reduction solely because blood pressure is markedly elevated. [18][19] |
| No acute target-organ injury | Initiate or adjust oral therapy and address adherence barriers; arrange follow-up. [6][18] | Reduce gradually over days to weeks; avoid aggressive lowering and parenteral agents. [18] |

## References
1. [PDF] General Issues Panel – Clinical Evaluation of Anti-Hypertensive ... — www.fda.gov — https://www.fda.gov/media/171413/download
2. Evaluation and management of hypertensive emergency — www.bmj.com — https://www.bmj.com/content/bmj/386/bmj-2023-077205.full.pdf
3. Prevention, Detection, Evaluation, and Management of High Blood ... — www.acpjournals.org — https://www.acpjournals.org/doi/10.7326/M17-3203
4. J-Shaped Relationship between Blood Pressure and Mortality in ... — www.acpjournals.org — https://www.acpjournals.org/doi/10.7326/0003-4819-136-6-200203190-00007
5. Under Pressure: Treatment of Acute Severe Hypertension (Hypertensive Crisis) - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S1089251625000228
6. ED-Relevant Takeaways from the New AHA/ACC Hypertension... : Emergency Medicine News — journals.lww.com — https://journals.lww.com/em-news/fulltext/2026/01000/ed_relevant_takeaways_from_the_new_aha_acc.9.aspx
7. Blood pressure management in cardiovascular emergencies: an ... : AME Medical Journal — journals.lww.com — https://journals.lww.com/amj/fulltext/2024/09000/blood_pressure_management_in_cardiovascular.7.aspx
8. Under Pressure: Treatment of Acute Severe Hypertension (Hypertensive Crisis) — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1089251625000228
9. Hypertensive Crisis - an overview | ScienceDirect Topics — www.sciencedirect.com — https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/hypertensive-crisis
10. The Degree of Blood Pressure Evaluation and End Organ Damage With Severe Hypertension: A Case-Control Study - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0002962915353866
11. Management of hypertensive crisis: British and Irish ... - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10539169
12. Current guidelines in hypertension management with special focus ... — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC12817854
13. Hypertensive Crisis - StatPearls - NCBI Bookshelf - NIH — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK507701
14. [PDF] Consultation on draft guideline - Stakeholder comments - NICE — www.nice.org.uk — https://www.nice.org.uk/guidance/ng136/documents/consultation-comments-and-responses-3
15. Management Strategies for Hypertensive Crisis: A Systematic Review — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC11389756
16. Acute Hypertension: A Systematic Review and Appraisal of Guidelines - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC4295743
17. Hypertensive Crisis - StatPearls - NCBI Bookshelf — ncbi.nlm.nih.gov — https://ncbi.nlm.nih.gov/books/NBK507701?report=printable
18. Severe Asymptomatic Hypertension: Evaluation and Treatment. - Abstract — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/28409616
19. Hypertensive Urgency - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/sites/books/NBK513351
20. Treatment of hypertensive emergencies — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440310
21. Hypertensive Crises — journal.chestnet.org — https://journal.chestnet.org/article/S0012-3692(15)37535-8/abstract
22. [PDF] A Diagnostic and Clinical Approach to the Practical Management of ... — applications.emro.who.int — https://applications.emro.who.int/imemrf/224/J-Med-Res-2020-6-4-120-124-eng.pdf
23. Effect of early treatment with anti‐hypertensive drugs on short and ... — www.cochranelibrary.com — https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006743.pub2/references
24. Hypertensive emergencies: Diagnosis and management — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0033062002700261

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.